Literature DB >> 17112921

Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review.

I R Schreibman1, P Bejarano, E J Martinez, A Regev.   

Abstract

Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.

Entities:  

Mesh:

Year:  2006        PMID: 17112921     DOI: 10.1016/j.transproceed.2006.08.095

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Late retroperitoneal recurrence of hepatocellular carcinoma 12 years after initial diagnosis.

Authors:  Tiffany Cho-Lam Wong; Ka-Fai To; Simon See-Ming Hou; Sidney Kam-Hung Yip; Chi-Fai Ng
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma.

Authors:  Borja Hernández-Breijo; Jorge Monserrat; Sara Ramírez-Rubio; Eva P Cuevas; Diana Vara; Inés Díaz-Laviada; M Dolores Fernández-Moreno; Irene D Román; Javier P Gisbert; Luis G Guijarro
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

3.  Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.

Authors:  Christopher J Hoffmann; Aruna K Subramanian; Andrew M Cameron; Eric A Engels
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

4.  Long-term survival of patients with hepatocellular carcinoma with pulmonary and adrenal metastasis: A case report.

Authors:  H Y Zhang; Q J Wu; C H Xie; G Zhang
Journal:  Exp Ther Med       Date:  2012-01-16       Impact factor: 2.447

5.  Late recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Julia A Zhang; Sandi A Kwee; Linda L Wong
Journal:  Hepatoma Res       Date:  2017-04-10

6.  Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology.

Authors:  R Biffi; F Orsi; M G Zampino; A Chiappa; N Fazio; F De Braud; G Bonomo; L Monfardini; P D Vigna; F Luca; L Bodei; M Bartolomei; G Catalano; M C Leonardi; M Ferrari; B Andreoni; A Goldhirsch; G Paganelli; R Orecchia
Journal:  Ecancermedicalscience       Date:  2008-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.